NeoMedLight

Phototherapy at home with the BiliCocoon: Isabel's story

ISABEL’S STORY
Stories
When my daughter Alina was born at 30 weeks gestation it came as a huge shock and commenced our long NICU journey. During the early days Alina was quite unwell and was receiving numerous medications and breathing support. During this time, she also had constant blue light therapy to help with jaundice. During her time receiving this treatment we struggled to find suitable times for care moments and time to be held. Although I knew she was receiving the best treatment it was so hard to watch my baby and not being able to comfort and support her in my arms.
Following our discharge we discovered the Newborn Intensive Care
Foundation and have built a strong relationship with them and I have personally grown a passion for giving back and raising awareness of the challenges that families with sick newborns face. Discovering the changes that the Bilicocoon will bring to families is absolutely amazing. The NICU can be such a daunting place and just being able to be close with your baby and hold them and support them through any kind of treatment is so rewarding. The Bilicocoon enables families to continue building those bonds with their children and advocates for families to be a further part of their child’s development.

For more information about BiliCocoon: [email protected]

The Neonatology Department at Birmingham University Hospital, under the direction of Dr. Mupanemunda, has treated more than 1,000 newborns at home with Bilicocoon.

The Bilicocoon, while preserving the mother-child relationship, allows for a simple, effective and safe treatment in the hospital or at home.
Home treatment with the BiliCocoon has been the subject of a published study (Noureldein M, et al. BMJ Paediatrics Open 2021;5:e001027. doi:10.1136/bmjpo-2021-001027 1)

A study conducted at the CNRHP/Maternité de Rouen over a 2-year period concluded the following

- No separation of mother and child.
- Space-saving contact phototherapy.
- No interruption of feeding during treatment of jaundice.
- Low risk of hyperthermia, no increased water loss.
- Reduced invasive efficacy monitoring as Btc is still possible on the forehead.
- No continuous cardiorespiratory monitoring/no eye protection. AND this is especially true for those without haemolytic pathology.

⚫ Results are in favour of extending the use of
Bilicocoon in maternity wards

A study published in the European Journal of Pediatrics demonstrates the feasibility, safety and efficacy of the Billicocoon Bag System in the treatment of newborn jaundice at home

Discharge of newborns with risk factors of severe hyperbilirubinemia:
description of a hospital at home‑based care monitoring
and phototherapy
Sarah Spyridakis Coquery · Alexandre Georges · Anne Cortey · Corinne Floch · David Avran · Edith Gatbois ·
Claire Mehler‑Jacob · Matthieu de Stampa

With Bilicocoon, newborn jaundice can be treated at home

https://www.neomedlight.com/bilicocoon/

You are personally concerned or a loved one is currently being treated for cancer.
Oral mucositis is one of the most debilitating side effects of radiation and/or chemotherapy treatment.
It has a significant impact on quality of life and the potential to interrupt or stop cancer treatment.
Photobiomodulation with the CareMin650 provides both a preventive and curative solution to this problem.

More information on the NeoMedLight website or ask for information to your doctor

UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST and NeoMedLight celebrate 500 babies treated for newborn jaundice with Bilicocoon home phototherapy
Bilicocoon® is a unique phototherapy system for the treatment of newborn jaundice based on light emission from a luminous tissue.
This system allows the baby to be treated in hospital or at home and preserves the mother-child relationship.

UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST et NeoMedLight fêtent les 500 bébés traités pour la jaunisse du nouveau-né grâce à la photothérapie à domicile Bilicocoon.
Bilicocoon® est un système unique de photothérapie pour le traitement de la jaunisse du nouveau-né basé sur une émission de lumière par un tissus lumineux.
Ce système permet une prise ne charge du bébé à l'hôpital ou à domicile et préserve la relation mère – enfant

According to the World Health Organisation, skin-to-skin contact is the best way to develop an infant's immunity. ⬇️

The Bilicocoon allows you to maintain the relationship with your baby while providing effective treatment for jaundice.

https://www.who.int/news/item/16-03-2021-new-research-highlights-risks-of-separating-newborns-from-mothers-during-covid-19-pandemic?fbclid=IwAR2gBG-CWUxNqSi6sYM14y_of3x3gaS0Xry7cssHWz8S7tRRmTffqYYzaF4

New research highlights risks of separating newborns from mothers during COVID-19 pandemic New research from WHO and partners shows that the COVID-19 pandemic is severely affecting the quality of care given to small and sick newborns, resulting in unnecessary suffering and deaths.

NeoMedLight updated their business hours.

The BiliCocoon works with an innovative technology called Lightex Technology. Discover in this video how the BiliCocoon provides a safe and effective treatment for your baby!

https://youtu.be/Ohlnm0EHink

BiliCocoon® - Lightex Technology What is Lightex technology? Explanation of what this innovative technology used in BiliCocoon® systems is. The promise? A heat-free, comfortable and effectiv...

The BiliCocoon is lightweight, easy to carry and flexible, making it suitable for use in hospitals and at home.